Fenofibrate is an agonist of peroxisome proliferator-activated receptor α (PPARα), which promotes fatty acid β-oxidation and oxidative phosphorylation, both pathways decreased in ADPKD (Lakhia et al. 2018). Here, PPARA is linked to autosomal dominant polycystic kidney disease.